Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa

Laurence H M Pierrache, Bas P Hartel, Erwin van Wijk, Magda A Meester-Smoor, Frans P M Cremers, Elfride de Baere, Julie de Zaeytijd, Mary J van Schooneveld, Cor W R J Cremers, Gislin Dagnelie, Carel B Hoyng, Arthur A Bergen, Bart P Leroy, Ronald J E Pennings, L Ingeborgh van den Born, Caroline C W Klaver

Research output: Contribution to journalArticleResearchpeer-review


PURPOSE: USH2A mutations are an important cause of retinitis pigmentosa (RP) with or without congenital sensorineural hearing impairment. We studied genotype-phenotype correlations and compared visual prognosis in Usher syndrome type IIa and nonsyndromic RP.

DESIGN: Clinic-based, longitudinal, multicenter study.

PARTICIPANTS: Consecutive patients with Usher syndrome type IIa (n = 152) and nonsyndromic RP (n = 73) resulting from USH2A mutations from ophthalmogenetic clinics in the Netherlands and Belgium.

METHODS: Data on clinical characteristics, visual acuity, visual field measurements, retinal imaging, and electrophysiologic features were extracted from medical charts over a mean follow-up of 9 years. Cumulative lifetime risks of low vision and blindness were estimated using Kaplan-Meier survival analysis.

MAIN OUTCOME MEASURES: Low vision and blindness.

RESULTS: Participant groups had similar distributions of gender (48% vs. 45% males in Usher syndrome type IIa vs. nonsydromic RP; P = 0.8), ethnicity (97% vs. 99% European; P = 0.3), and median follow-up time (6.5 years vs. 3 years; P = 0.3). Usher syndrome type IIa patients demonstrated symptoms at a younger age (median age, 15 years vs. 25 years; P < 0.001), were diagnosed earlier (median age, 26 years vs. 36.5 years; P < 0.001), and became visually impaired 13 years earlier (median age, 41 years vs. 54 years; P < 0.001) based on VF and 18 years earlier based on VA (median age, 54 years vs. 72 years; P < 0.001) than nonsyndromic RP patients. The presence of 2 truncating mutations in USH2A was associated mostly with the syndromic phenotype, whereas other combinations were present in both groups. We found novel variants in Usher syndrome type IIa (25%) and nonsyndromic RP (19%): 29 missense mutations, 10 indels, 14 nonsense mutations, 9 frameshift mutations, and 5 splice-site mutations.

CONCLUSIONS: Most patients with USH2A-associated RP have severe visual impairment by age 50. However, those with Usher syndrome type IIa have an earlier decline of visual function and a higher cumulative risk of visual impairment than those without nonsyndromic RP. Complete loss of function of the USH2A protein predisposes to Usher syndrome type IIa, but remnant protein function can lead to RP with or without hearing loss.

Original languageEnglish
Pages (from-to)1151-60
Number of pages10
Issue number5
Publication statusPublished - May 2016


  • Adolescent
  • Adult
  • Aged
  • Blindness/physiopathology
  • DNA Mutational Analysis
  • Extracellular Matrix Proteins/genetics
  • Female
  • Follow-Up Studies
  • Genetic Association Studies
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Prognosis
  • Retinitis Pigmentosa/genetics
  • Usher Syndromes/genetics
  • Vision, Low/physiopathology
  • Visual Acuity/physiology
  • Visual Fields/physiology


Dive into the research topics of 'Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa'. Together they form a unique fingerprint.

Cite this